Abbott Cardiovascular is a leading medical device company based in the United States. Established in 2016 as a division of Abbott Laboratories, it focuses on the development and manufacturing of innovative products and therapies to treat various cardiovascular diseases. The company's headquarters is located in Santa Clara, California.

Abbott Cardiovascular offers a wide range of products and services aimed at improving patient care and outcomes. Its portfolio includes coronary stents, transcatheter heart valves, vascular closure devices, ventricular assist devices, and electrophysiology products. These medical devices are designed to treat conditions such as coronary artery disease, heart failure, and arrhythmias.

Operating on a global scale, Abbott Cardiovascular has established subsidiaries, joint ventures, and partnerships in various countries. It has collaborated with leading healthcare institutions and organizations to conduct clinical trials and develop cutting-edge technologies. Noteworthy partnerships include collaborations with Medtronic for drug-eluting stents and Boston Scientific for transcatheter aortic valve replacement.

Abbott Cardiovascular holds a significant position in the global medical device market, particularly in the cardiovascular segment. With a strong presence in the United States, Europe, and developing markets, the company has achieved substantial global sales. It competes with other major players in the cardiovascular field, such as Medtronic, Boston Scientific, and Edwards Lifesciences.

Over the years, Abbott Cardiovascular has achieved several milestones and made notable achievements in the field of cardiovascular medicine. It has introduced innovative products that have revolutionized patient care and improved clinical outcomes. In recent years, the company has focused on expanding its product lineup through strategic acquisitions and in-house research and development.

Currently, Abbott Cardiovascular continues to innovate and develop new therapies to address unmet medical needs in the cardiovascular field. It is committed to enhancing patient outcomes and providing healthcare professionals with advanced solutions to treat cardiovascular diseases. By staying at the forefront of medical technology, Abbott Cardiovascular aims to improve the lives of millions of patients worldwide